scholarly journals Mo1272 WIDE-AREA TRANSEPITHELIAL SAMPLING IN ADJUNCT TO FORCEPS BIOPSY INCREASES THE DIAGNOSTIC YIELD OF RECURRENT OR RESIDUAL BARRETT’S ESOPHAGUS IN PATIENTS WHO UNDERWENT ENDOSCOPIC TREATMENT: A META-ANALYSIS AND SYSTEMATIC REVIEW

2020 ◽  
Vol 91 (6) ◽  
pp. AB410
Author(s):  
Vishnu Charan Suresh Kumar ◽  
Abinash Subedi ◽  
Venkata Suresh Patthipati ◽  
Prateek S. Harne ◽  
Bishnu Sapkota
Keyword(s):  
Systematic Review ◽  
Barrett’S Esophagus ◽  
Endoscopic Treatment ◽  
Barrett's Esophagus ◽  
Diagnostic Yield ◽  
Meta Analysis ◽  
Wide Area ◽  
Forceps Biopsy

Wide-area transepithelial sampling for dysplasia detection in Barrett’s esophagus: a systematic review and meta-analysis

2021 ◽  
Author(s):  
D. Chamil Codipilly ◽  
Apoorva Krishna Chandar ◽  
Kenneth K. Wang ◽  
David A. Katzka ◽  
John R. Goldblum ◽  
...  
Keyword(s):  
Systematic Review ◽  
Barrett’S Esophagus ◽  
Barrett's Esophagus ◽  
Meta Analysis ◽  
Wide Area

scholarly journals Mo1246 CLINICAL APPLICABILITY OF WIDE AREA TRANSEPITHELIAL SAMPLING (WATS-3D) IN SCREENING & SURVEILLANCE OF BARRETT'S ESOPHAGUS - A SYSTEMATIC REVIEW & SENSITIVITY META-ANALYSIS

2020 ◽  
Vol 91 (6) ◽  
pp. AB395-AB396
Author(s):  
Saurabh Chandan ◽  
Harmeet S. Mashiana ◽  
Babu P. Mohan ◽  
Banreet S. Dhindsa ◽  
Amaninder J. Dhaliwal ◽  
...  
Keyword(s):  
Systematic Review ◽  
Barrett’S Esophagus ◽  
Barrett's Esophagus ◽  
Meta Analysis ◽  
Wide Area ◽  
Clinical Applicability

Post Endoscopy Barrett’s Neoplasia (PEBN) After A Negative Index Endoscopy: A Systematic Review & Proposal For Definitions and Performance Measures in Endoscopy

Endoscopy ◽  
2022 ◽  
Author(s):  
Madhav Desai ◽  
David A Lieberman ◽  
Sachin Srinivasan ◽  
Venkat Nutalapati ◽  
Abhishek Challa ◽  
...  
Keyword(s):  
Systematic Review ◽  
Barrett’S Esophagus ◽  
Barrett's Esophagus ◽  
Meta Analysis ◽  
Incidence Rates ◽  
High Rate ◽  
Negative Index ◽  
Inclusion Criteria ◽  
Surveillance Interval ◽  
And Performance

Background and aims: A high rate of neoplasia (high grade dysplasia; HGD and esophageal adenocarcinoma; EAC) has been reported in Barrett’s Esophagus at index endoscopy but precise rates of post endoscopy Barrett’s neoplasia (PEBN) are unknown. Methods: Systematic review and meta-analysis was performed examining electronic databases (inception to October 2021) for studies reporting PEBN. Consistent with definitions of Post Colonoscopy Colorectal Cancer as proposed by the World Endoscopy Organization, we defined neoplasia(HGD/EAC) detected at index endoscopy and/or within 6 months of a negative index endoscopy as “prevalent” neoplasia; those detected after 6 months of a negative index endoscopy and prior to next surveillance interval(i.e. 3 years) as PEBN or “interval” neoplasia, and those detected after 36 months of a negative index endoscopy as “incident” neoplasia. Pooled incidence rates and proportion relative to total neoplasia were analyzed. Results: 11 studies (n=59,795, age:62.3±3.3 years, 61%males) met inclusion criteria. The pooled incidence rates were: prevalent neoplasia 4.5% (95%confidence interval: 2.2-8.9) at baseline and additional 0.3%(0.1-0.7) within first 6 months, PEBN 0.52%(0.48-0.58) and incident neoplasia: 1.41%(0.93-2.14). At 3 years from index endoscopy, PEBN accounted for 3% while prevalent neoplasia accounted for 97% of total Barrett’s neoplasia. Conclusion: Neoplasia detected at or within 6 months of index endoscopy account for most of the Barrett’s neoplasia(>90%). Post-Endoscopy Barrett’s Neoplasia account for ~3% of cases and can be used for validation in future. This highlights the importance of a high-quality index endoscopy in Barrett’s Esophagus and the need to establish quality benchmarks to measure endoscopists’ performance.

Sign in / Sign up

Export Citation Format

Share Document